chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity, Vaccination site pruritus, Vaccination site urticaria
Clinical narrative: hives around the vaccination site about across two inches; itching at the injection site; nauseous; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE URTICARIA (hives around the vaccination site about across two inches), NAUSEA (nauseous), PAIN IN EXTREMITY (Sore arm) and VACCINATION SITE PRURITUS (itching at the injection site) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     The patient's past medical history included No adverse event.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced NAUSEA (nauseous) and PAIN IN EXTREMITY (Sore arm). On 11-Feb-2021, the patient experienced VACCINATION SITE URTICARIA (hives around the vaccination site about across two inches) and VACCINATION SITE PRURITUS (itching at the injection site). On 05-Feb-2021, NAUSEA (nauseous) and PAIN IN EXTREMITY (Sore arm) had resolved. On 12-Feb-2021, VACCINATION SITE URTICARIA (hives around the vaccination site about across two inches) and VACCINATION SITE PRURITUS (itching at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Cold sweat, Nausea
Clinical narrative: Cold sweats; Nauseous; This spontaneous case was reported by a consumer and describes the occurrence of COLD SWEAT (Cold sweats) and NAUSEA (Nauseous) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No adverse event history).    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COLD SWEAT (Cold sweats) and NAUSEA (Nauseous). At the time of the report, COLD SWEAT (Cold sweats) and NAUSEA (Nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Extremely Nauseated; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Extremely Nauseated) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced NAUSEA (Extremely Nauseated). At the time of the report, NAUSEA (Extremely Nauseated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: itchiness around the injection site; rash around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchiness around the injection site) and VACCINATION SITE RASH (rash around the injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itchiness around the injection site) and VACCINATION SITE RASH (rash around the injection site). At the time of the report, VACCINATION SITE PRURITUS (itchiness around the injection site) and VACCINATION SITE RASH (rash around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Ocular hyperaemia
Clinical narrative: Eyes feel hot like she is about to get a fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of OCULAR HYPERAEMIA (Eyes feel hot like she is about to get a fever) and CHILLS (Chills) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced OCULAR HYPERAEMIA (Eyes feel hot like she is about to get a fever) and CHILLS (Chills). At the time of the report, OCULAR HYPERAEMIA (Eyes feel hot like she is about to get a fever) and CHILLS (Chills) outcome was unknown.            Reporter did not allow further contact
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pruritus, Tenderness
Clinical narrative: won't stop itching/itching is just driving me crazy/Itched all day and all night; Very sore arm/Arm hurt terribly for a couple of days; Arm is tender; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (won't stop itching/itching is just driving me crazy/Itched all day and all night), TENDERNESS (Arm is tender) and PAIN IN EXTREMITY (Very sore arm/Arm hurt terribly for a couple of days) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No recorded medical history).    On 09-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced TENDERNESS (Arm is tender). On 10-Feb-2021, the patient experienced PRURITUS (won't stop itching/itching is just driving me crazy/Itched all day and all night) and PAIN IN EXTREMITY (Very sore arm/Arm hurt terribly for a couple of days). At the time of the report, PRURITUS (won't stop itching/itching is just driving me crazy/Itched all day and all night) had not resolved and TENDERNESS (Arm is tender) and PAIN IN EXTREMITY (Very sore arm/Arm hurt terribly for a couple of days) outcome was unknown.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Myalgia, Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Vaccination site was warm; Lack of appetite; Vaccination site was swollen knot; Vaccination site erythema; Vaccination site was sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Vaccination site was warm), DECREASED APPETITE (Lack of appetite), VACCINATION SITE SWELLING (Vaccination site was swollen knot), VACCINATION SITE ERYTHEMA (Vaccination site erythema) and MYALGIA (Vaccination site was sore) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in October 2020. Previously administered products included for an unreported indication: Steroid shot (Steroid shot) on 25-Jan-2021.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Vaccination site was warm), DECREASED APPETITE (Lack of appetite), VACCINATION SITE SWELLING (Vaccination site was swollen knot), VACCINATION SITE ERYTHEMA (Vaccination site erythema) and MYALGIA (Vaccination site was sore). On 07-Feb-2021, DECREASED APPETITE (Lack of appetite) outcome was unknown. At the time of the report, VACCINATION SITE WARMTH (Vaccination site was warm), VACCINATION SITE SWELLING (Vaccination site was swollen knot), VACCINATION SITE ERYTHEMA (Vaccination site erythema) and MYALGIA (Vaccination site was sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: patient received the first dose of the Pfizer vaccine on 10Feb2021 and today, 02Mar2021, return and mistakenly received a dose of the Moderna vaccine; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of WRONG PRODUCT ADMINISTERED (patient received the first dose of the Pfizer vaccine on 10Feb2021 and today, 02Mar2021, return and mistakenly received a dose of the Moderna vaccine) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.). Previously administered products included for an unreported indication: COVID-19 VACCINE (Patient received their 1st dose from Pfizer on 10th feb 2021) on 10-Feb-2021.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced WRONG PRODUCT ADMINISTERED (patient received the first dose of the Pfizer vaccine on 10Feb2021 and today, 02Mar2021, return and mistakenly received a dose of the Moderna vaccine). On 02-Mar-2021, WRONG PRODUCT ADMINISTERED (patient received the first dose of the Pfizer vaccine on 10Feb2021 and today, 02Mar2021, return and mistakenly received a dose of the Moderna vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.; Reporter's Comments: This report refers to a case of wrong vaccine administered for mRNA-1273, lot # 030M20Awith no associated AEs.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Pyrexia
Clinical narrative: difficulty breathing; high temperature; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (difficulty breathing) and PYREXIA (high temperature) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced DYSPNOEA (difficulty breathing) and PYREXIA (high temperature). At the time of the report, DYSPNOEA (difficulty breathing) and PYREXIA (high temperature) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Feeling hot, Vaccination site pruritus
Clinical narrative: weak; Tired; felt warm but does not know if they had a fever; itching at the injection; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weak), FATIGUE (Tired), FEELING HOT (felt warm but does not know if they had a fever) and VACCINATION SITE PRURITUS (itching at the injection) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No past medical history was reported.     On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced ASTHENIA (weak), FATIGUE (Tired) and FEELING HOT (felt warm but does not know if they had a fever). On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PRURITUS (itching at the injection). At the time of the report, ASTHENIA (weak), FATIGUE (Tired), FEELING HOT (felt warm but does not know if they had a fever) and VACCINATION SITE PRURITUS (itching at the injection) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided. No concomitant product was reported.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Eye swelling, Lip swelling
Clinical narrative: Eyes swollen; Lips swollen; This spontaneous case was reported by a consumer and describes the occurrence of EYE SWELLING (Eyes swollen) and LIP SWELLING (Lips swollen) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EYE SWELLING (Eyes swollen) and LIP SWELLING (Lips swollen). At the time of the report, EYE SWELLING (Eyes swollen) and LIP SWELLING (Lips swollen) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: significant follow up received on 20 JUL 2021, Outcome of events updated.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea, Headache, Paraesthesia
Clinical narrative: difficulty breathing; tightness in chest; tingling in face; headache; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (difficulty breathing), CHEST DISCOMFORT (tightness in chest), PARAESTHESIA (tingling in face) and HEADACHE (headache) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced DYSPNOEA (difficulty breathing), CHEST DISCOMFORT (tightness in chest), PARAESTHESIA (tingling in face) and HEADACHE (headache). At the time of the report, DYSPNOEA (difficulty breathing), CHEST DISCOMFORT (tightness in chest), PARAESTHESIA (tingling in face) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment details were not provided.
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: 46 days since first dose and has not yet received second dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (46 days since first dose and has not yet received second dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (46 days since first dose and has not yet received second dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (46 days since first dose and has not yet received second dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product use was reported. Treatment information was not available. Patient has refused to take the second vaccination dose, later again patient wanted to have the second dose which was after 46 days.   Most recent FOLLOW-UP information incorporated above includes: On 26-Mar-2021: NNI; Reporter's Comments: This report refers to a case of Inappropriate schedule of vaccine administered. for mRNA-1273, lot # unknown with no associated AEs.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Headache, Pyrexia, Rash, Swelling face
Clinical narrative: Face is extremely swollen with her lips; Felt like all bone was hurting; High Fever; Rash on her chest and stomach; Headache; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (Face is extremely swollen with her lips), BONE PAIN (Felt like all bone was hurting), PYREXIA (High Fever), RASH (Rash on her chest and stomach) and HEADACHE (Headache) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032LL20A and 031L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).   On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced SWELLING FACE (Face is extremely swollen with her lips), BONE PAIN (Felt like all bone was hurting), PYREXIA (High Fever), RASH (Rash on her chest and stomach) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, SWELLING FACE (Face is extremely swollen with her lips), BONE PAIN (Felt like all bone was hurting), PYREXIA (High Fever), RASH (Rash on her chest and stomach) and HEADACHE (Headache) outcome was unknown.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Bedridden, Chills, Feeling abnormal, Hyperhidrosis
Clinical narrative: Weak; Sweat; Cold; was like an old creepy; couldnot get out of bed; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weak), HYPERHIDROSIS (Sweat), NASOPHARYNGITIS (Cold), FEELING ABNORMAL (was like an old creepy) and BEDRIDDEN (couldnot get out of bed) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Weak), HYPERHIDROSIS (Sweat), NASOPHARYNGITIS (Cold), FEELING ABNORMAL (was like an old creepy), BEDRIDDEN (couldnot get out of bed), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, ASTHENIA (Weak) had not resolved and HYPERHIDROSIS (Sweat), NASOPHARYNGITIS (Cold), FEELING ABNORMAL (was like an old creepy), BEDRIDDEN (couldnot get out of bed), PYREXIA (Fever) and CHILLS (Chills) had resolved.            no concomitant medication information  was provided  no treatment product information was provided
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Nasopharyngitis, Pyrexia
Clinical narrative: Weak; Sweat; Cold; was like an old creepy; couldnot get out of bed; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weak), HYPERHIDROSIS (Sweat), NASOPHARYNGITIS (Cold), FEELING ABNORMAL (was like an old creepy) and BEDRIDDEN (couldnot get out of bed) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Weak), HYPERHIDROSIS (Sweat), NASOPHARYNGITIS (Cold), FEELING ABNORMAL (was like an old creepy), BEDRIDDEN (couldnot get out of bed), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, ASTHENIA (Weak) had not resolved and HYPERHIDROSIS (Sweat), NASOPHARYNGITIS (Cold), FEELING ABNORMAL (was like an old creepy), BEDRIDDEN (couldnot get out of bed), PYREXIA (Fever) and CHILLS (Chills) had resolved.            no concomitant medication information  was provided  no treatment product information was provided
Sex: M
Vaccine: COVID19
Symptoms: Gastroenteritis
Clinical narrative: Stomach bug; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of GASTROENTERITIS (Stomach bug) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M820A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced GASTROENTERITIS (Stomach bug). At the time of the report, GASTROENTERITIS (Stomach bug) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medications reported. no treatment details reported.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Follow-up received on 14-jul-2021,does not contain any new information.; Sender's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chest discomfort, Erythema, Hypoaesthesia oral, Oropharyngeal pain
Clinical narrative: Heaviness on her chest; Neck is itchy; Random joint pain; Sore joint; Sore knees; Sore ankles; Irregular "splatches" or patches of discoloration on both of her upper arms, but definitely more so on her left arm, where the vaccine was injected; Sore throat; Redness on her neck; Redness on her chest; Rash on her neck / neck is slightly rashy; Rash on her chest; Lightly numb tongue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPOAESTHESIA ORAL (Lightly numb tongue), VACCINATION SITE DISCOLOURATION (Irregular "splatches" or patches of discoloration on both of her upper arms, but definitely more so on her left arm, where the vaccine was injected), OROPHARYNGEAL PAIN (Sore throat), CHEST DISCOMFORT (Heaviness on her chest) and ERYTHEMA (Redness on her neck) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter and concomitant drugs are provided.  Concomitant products included PROGESTERONE for Birth control pill.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced HYPOAESTHESIA ORAL (Lightly numb tongue), OROPHARYNGEAL PAIN (Sore throat) and ERYTHEMA (Redness on her chest). 25-Jan-2021, the patient experienced ERYTHEMA (Redness on her neck), RASH (Rash on her neck / neck is slightly rashy) and RASH (Rash on her chest). On 26-Jan-2021, the patient experienced VACCINATION SITE DISCOLOURATION (Irregular "splatches" or patches of discoloration on both of her upper arms, but definitely more so on her left arm, where the vaccine was injected), ARTHRALGIA (Sore joint), ARTHRALGIA (Sore knees) and ARTHRALGIA (Sore ankles). On an unknown date, the patient experienced CHEST DISCOMFORT (Heaviness on her chest), PRURITUS (Neck is itchy) and ARTHRALGIA (Random joint pain). At the time of the report, HYPOAESTHESIA ORAL (Lightly numb tongue), VACCINATION SITE DISCOLOURATION (Irregular "splatches" or patches of discoloration on both of her upper arms, but definitely more so on her left arm, where the vaccine was injected), OROPHARYNGEAL PAIN (Sore throat), CHEST DISCOMFORT (Heaviness on her chest), ERYTHEMA (Redness on her neck), ERYTHEMA (Redness on her chest), PRURITUS (Neck is itchy), ARTHRALGIA (Sore joint), ARTHRALGIA (Sore knees), ARTHRALGIA (Sore ankles), ARTHRALGIA (Random joint pain), RASH (Rash on her neck / neck is slightly rashy) and RASH (Rash on her chest) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment for the event included diphenhydramine (Benadryl)
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Vaccination site discolouration
Clinical narrative: Heaviness on her chest; Neck is itchy; Random joint pain; Sore joint; Sore knees; Sore ankles; Irregular "splatches" or patches of discoloration on both of her upper arms, but definitely more so on her left arm, where the vaccine was injected; Sore throat; Redness on her neck; Redness on her chest; Rash on her neck / neck is slightly rashy; Rash on her chest; Lightly numb tongue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPOAESTHESIA ORAL (Lightly numb tongue), VACCINATION SITE DISCOLOURATION (Irregular "splatches" or patches of discoloration on both of her upper arms, but definitely more so on her left arm, where the vaccine was injected), OROPHARYNGEAL PAIN (Sore throat), CHEST DISCOMFORT (Heaviness on her chest) and ERYTHEMA (Redness on her neck) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter and concomitant drugs are provided.  Concomitant products included PROGESTERONE for Birth control pill.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced HYPOAESTHESIA ORAL (Lightly numb tongue), OROPHARYNGEAL PAIN (Sore throat) and ERYTHEMA (Redness on her chest). 25-Jan-2021, the patient experienced ERYTHEMA (Redness on her neck), RASH (Rash on her neck / neck is slightly rashy) and RASH (Rash on her chest). On 26-Jan-2021, the patient experienced VACCINATION SITE DISCOLOURATION (Irregular "splatches" or patches of discoloration on both of her upper arms, but definitely more so on her left arm, where the vaccine was injected), ARTHRALGIA (Sore joint), ARTHRALGIA (Sore knees) and ARTHRALGIA (Sore ankles). On an unknown date, the patient experienced CHEST DISCOMFORT (Heaviness on her chest), PRURITUS (Neck is itchy) and ARTHRALGIA (Random joint pain). At the time of the report, HYPOAESTHESIA ORAL (Lightly numb tongue), VACCINATION SITE DISCOLOURATION (Irregular "splatches" or patches of discoloration on both of her upper arms, but definitely more so on her left arm, where the vaccine was injected), OROPHARYNGEAL PAIN (Sore throat), CHEST DISCOMFORT (Heaviness on her chest), ERYTHEMA (Redness on her neck), ERYTHEMA (Redness on her chest), PRURITUS (Neck is itchy), ARTHRALGIA (Sore joint), ARTHRALGIA (Sore knees), ARTHRALGIA (Sore ankles), ARTHRALGIA (Random joint pain), RASH (Rash on her neck / neck is slightly rashy) and RASH (Rash on her chest) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment for the event included diphenhydramine (Benadryl)
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Feeling abnormal, Pain in extremity
Clinical narrative: the pain went over to his left upper chest.; it got really bad for the whole day; The left arm he received the vaccine was pretty sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (The left arm he received the vaccine was pretty sore), FEELING ABNORMAL (it got really bad for the whole day) and CHEST PAIN (the pain went over to his left upper chest.) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011620A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jan-2021, the patient experienced PAIN IN EXTREMITY (The left arm he received the vaccine was pretty sore). On 18-Jan-2021, the patient experienced FEELING ABNORMAL (it got really bad for the whole day). On 19-Jan-2021, the patient experienced CHEST PAIN (the pain went over to his left upper chest.). The patient was treated with IBUPROFEN at a dose of 800 mg. On 17-Jan-2021, PAIN IN EXTREMITY (The left arm he received the vaccine was pretty sore) had resolved. On 18-Jan-2021, FEELING ABNORMAL (it got really bad for the whole day) had resolved. On 19-Jan-2021, CHEST PAIN (the pain went over to his left upper chest.) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Diarrhoea, Pyrexia
Clinical narrative: Fever; Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and DIARRHOEA (Diarrhea) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M2UA) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced PYREXIA (Fever) and DIARRHOEA (Diarrhea). At the time of the report, PYREXIA (Fever) had resolved and DIARRHOEA (Diarrhea) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Feb-2021, Body temperature: high 100.1 degrees Fahrenheit. On 01-Mar-2021, Body temperature: high 100 degrees Fahrenheit.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site rash
Clinical narrative: red circle rash; developed red circle rash at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (red circle rash) and VACCINATION SITE ERYTHEMA (developed red circle rash at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (red circle rash) and VACCINATION SITE ERYTHEMA (developed red circle rash at the injection site). At the time of the report, VACCINATION SITE RASH (red circle rash) and VACCINATION SITE ERYTHEMA (developed red circle rash at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Dizziness, Hypersomnia, Hypertension, Lymphadenopathy
Clinical narrative: Blood pressure was 208; Light-headed; Extremely Sleepy; Lymph nodes was swollen for 30 minutes; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (Blood pressure was 208), DIZZINESS (Light-headed), HYPERSOMNIA (Extremely Sleepy) and LYMPHADENOPATHY (Lymph nodes was swollen for 30 minutes) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concurrent medical conditions included Vertigo. Concomitant products included CLONIDINE for Blood pressure management, NAPROXEN SODIUM (ALEVE) and LOSARTAN for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced HYPERTENSION (Blood pressure was 208), DIZZINESS (Light-headed), HYPERSOMNIA (Extremely Sleepy) and LYMPHADENOPATHY (Lymph nodes was swollen for 30 minutes). At the time of the report, HYPERTENSION (Blood pressure was 208), DIZZINESS (Light-headed), HYPERSOMNIA (Extremely Sleepy) and LYMPHADENOPATHY (Lymph nodes was swollen for 30 minutes) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Feb-2021, Blood pressure measurement: 208 (High) 208.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient took clonidine for blood pressure on way home and was extremely sleepy. She took losartan and felt sleepy, last night she called pharmacist and was told to take my losartan for the second time. Her niece was a nurse and checked blood pressure where it was dropping. On 05-Feb-2021, doctor said to take blood pressure medication. On 04-Feb-2021, the patient felt her lymph nodes was swollen for 30 minutes and clonidine has something to do with it, since that was taken 30 minutes after the vaccine and that makes her drowsy. She never experienced that feeling that way with that kind of sleepiness.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, Pain
Clinical narrative: Body pain; joint pain; Body aches; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PAIN (Body pain), ARTHRALGIA (joint pain) and MYALGIA (Body aches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (Body pain), ARTHRALGIA (joint pain) and MYALGIA (Body aches). At the time of the report, PAIN (Body pain), ARTHRALGIA (joint pain) and MYALGIA (Body aches) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-032195 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Tested positive for COVID after the first Moderna COVID-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for COVID after the first Moderna COVID-19 vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for COVID after the first Moderna COVID-19 vaccine). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for COVID after the first Moderna COVID-19 vaccine) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test positive: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.; Sender's Comments: Based on the mechanism of action of mRNA-1273 causal association between the event of tested positive for COVID-19 and mRNA-1273 is assessed as not applicable.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: I have already passed the 42 days to receive the 2nd dose; A spontaneous report was received from a 79-years-old female consumer (patient) who received Moderna's COVID-19 vaccine (mRNA-1273) and she had already passed the 42 days to receive the 2nd dose (Inappropriate schedule of vaccine administered).  The concomitant medications reported were triamterene, pravastatin, estradiol, methocarbamol, celecoxib, tramadol, omeprazole, acebutolol, pramipexole and gabapentin .  On 16 Jan 2021, the patient received her first of two planned doses of mRNA-1273 (lot/batch: 041L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection. The patient had been trying to schedule her second dose but was told by the vaccination provider that there were no available appointments until Sep 2021. The patient stated that she had already passed the 42 days window to receive the second dose.  The outcome of the event, she had already passed the 42 days to receive the 2nd dose, was unknown.  No further information was provided.; Reporter's Comments: This report refers to a case of Inappropriate schedule of vaccine administered for mRNA-1273, lot 041L20A with no associated AEs.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Nausea
Clinical narrative: Fatigue; Muscle soreness; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), MYALGIA (Muscle soreness) and NAUSEA (Nausea) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced FATIGUE (Fatigue), MYALGIA (Muscle soreness) and NAUSEA (Nausea). At the time of the report, FATIGUE (Fatigue), MYALGIA (Muscle soreness) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medicines were reported. No treatment information were reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown.            Based on the current available information and temporal association between the use of the product and the start date of this event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of this event, a causal relationship cannot be excluded.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Influenza like illness, Pain, Pyrexia
Clinical narrative: Flu like symptoms; Generalized aching; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN (Generalized aching), PYREXIA (Fever) and CHILLS (Chills) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product RISANKIZUMAB for Plaque psoriasis.    No Medical History information was reported.   On 18-Nov-2020, the patient started RISANKIZUMAB (Subcutaneous) at an unspecified dose. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2020, the patient experienced PYREXIA (Fever). In February 2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN (Generalized aching) and CHILLS (Chills). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms) had resolved and PAIN (Generalized aching), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Body temperature: unknown (Inconclusive) Unknown.         Treatment information was not provided.   This case was linked to MOD-2021-073087 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 31-May-2021: Follow-up information received on 31-May-2021 no new information was recorded
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: A spontaneous report was received from female patient of unspecified age who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events redness at the injection site, swelling at the injection site, warm to the touch at the injection site.  The patient's medical history was not provided. Concomitant medications included for High blood pressure, Esomeprazole  as antacid, Atorvastatin for cholesterol .   On 2 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (Batch number: 023L20A) via unknown route for prophylaxis of COVID-19 infection.  After receiving the vaccine, the patient experienced the events redness at the injection site, swelling at the injection site, warm to the touch the injection site.  Treatment details included acetaminophen.  Action taken with mRNA-1273 in response to the events were unknown.  The outcome of events redness at the injection site, swelling at the injection site, warm to the touch at the injection site was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Eye irritation, Eye pain, Pain
Clinical narrative: my eyes started burning, stinging and burning; my eyes started burning, stinging and burning; achy; This spontaneous case was reported by a consumer and describes the occurrence of EYE PAIN (my eyes started burning, stinging and burning), EYE IRRITATION (my eyes started burning, stinging and burning) and PAIN (achy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was reported.). Concomitant products included TRIAMCINOLONE ACETONIDE (NASACORT nasal spray), FEXOFENADINE HYDROCHLORIDE (ALLEGRA), MULTIVITAMINS [VITAMINS NOS] and MONTELUKAST SODIUM (SINGULAIR) for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PAIN (achy). On 04-Mar-2021, the patient experienced EYE PAIN (my eyes started burning, stinging and burning) and EYE IRRITATION (my eyes started burning, stinging and burning). At the time of the report, EYE PAIN (my eyes started burning, stinging and burning), EYE IRRITATION (my eyes started burning, stinging and burning) and PAIN (achy) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: Follow-up received included No New Information.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Headache, Influenza, Vaccination site pain
Clinical narrative: This spontaneous case was reported by a physician and describes the occurrence of INFLUENZA (flu/recurrent low grade flu), VACCINATION SITE PAIN (pain in arm/sore right arm) and HEADACHE (headache) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 010M20A) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Ulcerative colitis.    The patient's past medical history included Knee surgery NOS (in 1989 and 1990) and Colectomy NOS (Patient had surgeries for his ostomy pouch for over the next 20 years when his colon was removed.) in 1984. Previously administered products included for an unreported indication: CORTISONE (For Ulcerative colitis), SULFASALAZINE (For Ulcerative colitis) and PREDNISONE (For Ulcerative colitis). Concurrent medical conditions included Ulcerative colitis since December 1981, Diabetes and Arthritis. Concomitant products included IRON for Anemia, TRIAMCINOLONE ACETONIDE for Eczema, MESALAZINE (CANASA) for Inflammation, FORVIA for Ulcerative colitis, CYANOCOBALAMIN (VIT B12), TAMSULOSIN HYDROCHLORIDE (FLOMAX [TAMSULOSIN HYDROCHLORIDE]), AZATHIOPRINE and COLESEVELAM for an unknown indication.   In October 2020, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 40 mg every two weeks. On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Feb-2021, the patient experienced INFLUENZA (flu/recurrent low grade flu), VACCINATION SITE PAIN (pain in arm/sore right arm) and HEADACHE (headache). On 06-Feb-2021, VACCINATION SITE PAIN (pain in arm/sore right arm) had resolved. On 07-Feb-2021, INFLUENZA (flu/recurrent low grade flu) had resolved. At the time of the report, HEADACHE (headache) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Feb-2021, Body temperature: 100 (High) 100 F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Patient's medical history was corrected and historical drugs were added. Suspect details were updated.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Headache
Clinical narrative: Dizziness; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) and HEADACHE (Headache) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 91A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced DIZZINESS (Dizziness) and HEADACHE (Headache). At the time of the report, DIZZINESS (Dizziness) and HEADACHE (Headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.